Overview
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 27, 2026 | Morepen Labs Q4 Net Profit Rises 69 percent; CDMO Program Moves into Commercial Execution; Board Proposes a Dividend of 10 percent for FY 2025-26 | Gurugram, Haryana, India Morepen Laboratories Limited reported strong Q4 FY26 performance with net profit rising 69% YoY to Rs. 20 crore and gross revenue increasing 22% YoY to Rs. 472 crore. Revenue growth during the quarter was supported ... |
| Apr 20, 2026 | Morepen Labs' Facility Clears USFDA Inspection with NIL Adverse Observation for the Record Fourth Consecutive Time | Gurugram, Haryana, India Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has announced the successful completion of a USFDA (United States Food and Drug Administration) inspection at its Masulakhanna (Himachal) facility, with Ze... |
| Feb 23, 2026 | Morepen Bags Rs. 825 Crore Global Deal | Gurugram, Haryana, India Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has secured a multi-year Contract Development and Manufacturing Organization (CDMO) mandate valued at approximately Rs. 825 crore (USD 91 million) from a l... |
| Aug 8, 2025 | Morepen Laboratories Limited Expands to UAE: Step-Down Subsidiary in Dubai Mainland Support from Start Any Business | Mr. Kushal Suri (R), President – International Growth at Morepen Laboratories Ltd., and Mr. Pankaj Joshi (L), Sales Director at Start Any Business start any business logo DUBAI, DUBAI, UNITED ARAB EMIRATES, August 8, 2025 /EINPresswire.com/... |
| Dec 3, 2021 | Morepen Laboratories : gets USFDA Approval for Fexofinadine (Allegra) Expected to start export in Q4'FY22 | PRESS RELEASE Morepen gets USFDA Approval for Fexofinadine (Allegra) Expected to start export in Q4'FY22 New Delhi, December 3, 2021: Morepen Laboratories Limited (NSE: MOREPENLAB, BSE: 500288) has received USFDA approval for its anti-... |
| Nov 11, 2021 | Morepen records 70 percent increase in Profit before tax in Q2 Consolidated Revenue grows by 17% | PRESS RELEASE Morepen records 70 percent increase in Profit before tax in Q2 Consolidated Revenue grows by 17% Consolidated Quarterly performance at a glance (Rs. in crores) Particulars Q2' Q2' Y-o-Y FY 2021-22 FY 2020-21 Growth N... |
| Sep 29, 2021 | Morepen Laboratories : Press Release 29 September 2021 | Date: 29/09/2021 To, National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (East), Mumbai- 400 051 Dalal Street, Mumbai- 400 001 Symbol: MOREPENLAB Scrip Code: 500288 Subje... |
Reviews 0
FAQ about Morepen Laboratories
How much funding has Morepen Laboratories raised?
Morepen Laboratories has raised $95.62M in total across 1 funding round.
What has the press written about Morepen Laboratories?
Parsers VC has collected 8 articles mentioning Morepen Laboratories, among them “Morepen Labs Q4 Net Profit Rises 69 percent; CDMO Program Moves into Commercial Execution; Board Proposes a Dividend of 10 percent for FY 2025-26” (May 27, 2026) and “Morepen Labs' Facility Clears USFDA Inspection with NIL Adverse Observation for the Record Fourth Consecutive Time” (Apr 20, 2026).
Is Morepen Laboratories still active?
Yes, Morepen Laboratories is active; its latest activity on Parsers VC dates from Nov 2, 2026.